XML 44 R19.htm IDEA: XBRL DOCUMENT v3.22.0.1
Shareholders' Equity (Deficit)
12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Shareholders' Equity (Deficit)

11. SHAREHOLDERS’ EQUITY (DEFICIT)

This note reflects the share repurchases and related activity as well as share-based compensation activity recognized by the Company, for all periods referenced.

Return of capital 

On October 29, 2020, the Board of Directors authorized a stock repurchase program for the purchase of up to $1,000.0 million worth of shares of MSCI’s common stock in addition to the $804.5 million of authorization then remaining under a previously existing share repurchase program (the “2020 Repurchase Program”) for a total of $1,804.5 million of stock repurchase authorization.

Share repurchases made pursuant to the 2020 Repurchase Program may take place in the open market or in privately negotiated transactions from time to time based on market and other conditions. This authorization may be modified, suspended or terminated by the Board of Directors at any time without prior notice. As of December 31, 2021, there was $1,589.2 million of available authorization remaining under the 2020 Repurchase Program.  

 

The following table provides information with respect to repurchases of the Company’s common stock made on the open market:

 

Year Ended

 

Average

Price

Paid Per

Share

 

 

Total

Number of

Shares

Repurchased

 

 

Dollar

Value of

Shares

Repurchased

 

 

 

(in thousands, except per share data)

 

December 31, 2021

 

$

412.25

 

 

 

339

 

 

$

139,580

 

December 31, 2020

 

$

291.76

 

 

 

2,493

 

 

$

727,344

 

December 31, 2019

 

$

147.97

 

 

 

690

 

 

$

102,081

 

 

 

The following table presents dividends declared per common share as well as total amounts declared, distributed and deferred for the periods indicated

 

 

 

Dividends

 

 

 

Per Share

 

 

Declared

 

 

Distributed

 

 

(Released)/

Deferred

 

2021

 

(in thousands, except per share data)

 

Three Months Ended March 31,

 

$

0.78

 

 

$

65,947

 

 

$

66,153

 

 

$

(206

)

Three Months Ended June 30,

 

 

0.78

 

 

 

64,863

 

 

 

64,489

 

 

 

374

 

Three Months Ended September 30,

 

 

1.04

 

 

 

86,476

 

 

 

85,961

 

 

 

515

 

Three Months Ended December 31,

 

 

1.04

 

 

 

86,475

 

 

 

85,973

 

 

 

502

 

Year Ended December 31,

 

$

3.64

 

 

$

303,761

 

 

$

302,576

 

 

$

1,185

 

2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31,

 

$

0.68

 

 

$

59,233

 

 

$

59,455

 

 

$

(222

)

Three Months Ended June 30,

 

 

0.68

 

 

 

57,360

 

 

 

57,068

 

 

 

292

 

Three Months Ended September 30,

 

 

0.78

 

 

 

65,830

 

 

 

65,454

 

 

 

376

 

Three Months Ended December 31,

 

 

0.78

 

 

 

65,029

 

 

 

64,653

 

 

 

376

 

Year Ended December 31,

 

$

2.92

 

 

$

247,452

 

 

$

246,630

 

 

$

822

 

2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31,

 

$

0.58

 

 

$

55,339

 

 

$

57,988

 

 

$

(2,649

)

Three Months Ended June 30,

 

0.58

 

 

 

49,613

 

 

 

49,365

 

 

 

248

 

Three Months Ended September 30,

 

0.68

 

 

 

58,176

 

 

 

57,882

 

 

 

294

 

Three Months Ended December 31,

 

0.68

 

 

 

58,176

 

 

 

57,916

 

 

 

260

 

Year Ended December 31,

 

$

2.52

 

 

$

221,304

 

 

$

223,151

 

 

$

(1,847

)

 

Common Stock

The following table presents activity related to shares of common stock issued and repurchased for the periods indicated:

 

 

 

Common

 

 

Treasury

 

 

Common Stock

 

 

 

Stock Issued

 

 

Stock

 

 

Outstanding

 

Balance At December 31, 2018

 

 

130,029,926

 

 

 

(45,855,788

)

 

 

84,174,138

 

Dividend payable/paid

 

 

1,064

 

 

 

(585

)

 

 

479

 

Common stock issued and exercise of stock options

 

 

2,387,145

 

 

 

 

 

 

2,387,145

 

Shares withheld for tax withholding

 

 

 

 

 

(1,077,815

)

 

 

(1,077,815

)

Shares repurchased under stock repurchase programs

 

 

 

 

 

(689,891

)

 

 

(689,891

)

Shares issued to Directors

 

 

1,277

 

 

 

(403

)

 

 

874

 

Balance At December 31, 2019

 

 

132,419,412

 

 

 

(47,624,482

)

 

 

84,794,930

 

Dividend payable/paid

 

 

553

 

 

 

(337

)

 

 

216

 

Common stock issued

 

 

406,960

 

 

 

 

 

 

406,960

 

Shares withheld for tax withholding

 

 

 

 

 

(165,239

)

 

 

(165,239

)

Shares repurchased under stock repurchase programs

 

 

 

 

 

(2,492,994

)

 

 

(2,492,994

)

Shares issued to Directors

 

 

2,250

 

 

 

27,284

 

 

 

29,534

 

Balance At December 31, 2020

 

 

132,829,175

 

 

 

(50,255,768

)

 

 

82,573,407

 

Dividend payable/paid

 

 

268

 

 

 

(156

)

 

 

112

 

Common stock issued

 

 

331,427

 

 

 

 

 

 

331,427

 

Shares withheld for tax withholding

 

 

 

 

 

(133,431

)

 

 

(133,431

)

Shares repurchased under stock repurchase programs

 

 

 

 

 

(338,577

)

 

 

(338,577

)

Shares issued to Directors

 

 

1,308

 

 

 

5,203

 

 

 

6,511

 

Balance At December 31, 2021

 

 

133,162,178

 

 

 

(50,722,729

)

 

 

82,439,449

 

 

Share-Based Compensation

The Company regularly issues share-based compensation to its employees and directors who are not employees of the Company. The accounting guidance for share-based compensation requires measurement of

compensation cost for share-based awards at fair value and recognition of compensation cost over the service period, net of estimated forfeitures.

In February 2022, the Company granted a portion of its employees awards in the form of RSUs, PSUs and performance stock options (“PSOs”). The total number of units and options granted was 227,684. The aggregate fair value of the awards was $79.6 million. The RSUs granted in 2022 vest at the end of a three-year service period. The PSUs granted in 2022 vest at the end of a three-year service period, are subject to a one-year sale restriction and are also subject to the achievement of an absolute total shareholder return compounded annual growth rate, measured over a three-year period. The PSOs granted in 2022 vest and become exercisable at the end of a three-year service period and are subject to a performance condition based on the combined level of achievement of a cumulative revenue performance goal and a cumulative adjusted EPS performance goal, measured over a three-year period. All of these awards are subject to forfeiture under specific criteria set in the award agreements.

In connection with awards under its equity-based compensation and benefit plans, the Company is authorized to use newly-issued shares or certain shares of common stock held in treasury.

 

The following table presents the amount of share-based compensation expense by category for the periods indicated:

 

 

 

Years Ended

 

 

 

December 31,

 

 

December 31,

 

 

December 31,

 

(in thousands)

 

2021

 

 

2020

 

 

2019

 

Cost of revenues

 

$

17,285

 

 

$

14,523

 

 

$

11,190

 

Selling and marketing

 

 

14,411

 

 

 

13,545

 

 

 

14,943

 

Research and development

 

 

7,913

 

 

 

7,344

 

 

 

5,966

 

General and administrative

 

 

17,463

 

 

 

19,826

 

 

 

11,991

 

Other expense (income)

 

 

1,416

 

 

 

379

 

 

 

 

Total share-based compensation expense

 

$

58,488

 

 

$

55,617

 

 

$

44,090

 

 

The windfall tax benefits for share-based compensation expense related to RSUs, PSUs and other restricted stock unit awards (together, the “Share-based Awards”) as well as stock options granted to Company employees and to directors who are not employees of the Company were $22.3 million, $20.9 million and $82.5 million for the years ended December 31, 2021, 2020 and 2019, respectively.

As of December 31, 2021, $52.3 million of compensation cost related to MSCI unvested share-based awards granted to the Company’s employees and to directors who are not employees of the Company had not yet been recognized. The unrecognized compensation cost relating to unvested stock-based awards expected to vest will be recognized primarily over the next one to five years.

In connection with awards under its equity-based compensation and benefit plans, the Company is authorized to issue shares of common stock. As of December 31, 2021, 3.8 million shares of common stock were available for future grants under these plans.

Certain Company employees have been granted Share-based Awards pursuant to a share-based compensation plan. The plan provides for the deferral of a portion of certain employees’ discretionary compensation with awards made in the form of Share-based Awards. Recipients of Share-based Awards generally have rights to receive dividend equivalents that are subject to vesting. The Company reports the target number of PSUs granted unless it has determined, based on the actual achievement of performance measures, that an employee will receive a different amount of shares underlying the PSUs, in which case the Company reports the amount of shares employees are likely to receive.

The fair value of the PSUs on the award dates were estimated under the Monte Carlo method using the following assumptions:

 

 

 

Years Ended

 

 

 

December 31,

 

 

December 31,

 

 

December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Risk free interest rate

 

 

0.33

%

 

 

1.28

%

 

 

2.46

%

Historical stock price volatility

 

 

34.13

%

 

 

25.42

%

 

 

21.98

%

Term (in years)

 

 

4.0

 

 

 

3.8

 

 

 

3.7

 

Discount of Lack of Marketability

 

 

4.0

%

 

 

0.0

%

 

 

0.0

%

 

The risk-free interest rate was determined based on the yields available on U.S. Constant Maturity Treasury yield curve as of the valuation dates with a maturity commensurate with the terms.  The expected stock price volatility was determined using historical volatility. Since the PSU awards are dividend-protected, the assumed dividend yield applied in the valuation was 0.0%.

The following table presents activity concerning the Company’s vested and unvested Share-based Awards applicable to its employees (share data in thousands) for the period indicated:

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

Grant

 

 

 

Number of

 

 

Date Fair

 

For the Year Ended December 31, 2021

 

Shares

 

 

Value

 

Vested and unvested Share-based Awards at

   December 31, 2020

 

 

739

 

 

$

163.99

 

Granted

 

 

330

 

 

$

265.99

 

Conversion to common stock

 

 

(340

)

 

$

153.66

 

Canceled

 

 

(32

)

 

$

274.66

 

Vested and unvested Share-based Awards at

   December 31, 2021 (1)

 

 

697

 

 

$

217.05

 

 

(1)

As of December 31, 2021, 639 Share-based Awards, with a weighted average grant date fair value of $213.70, were vested or expected to vest.

The total fair value of Share-based Awards held by the Company’s employees that converted to MSCI common stock during the years ended December 31, 2021, 2020 and 2019 was $152.6 million, $133.6 million and $401.7 million, respectively.

The following table presents activity concerning the Company’s unvested Share-based Awards related to its employees (share data in thousands):

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

Grant

 

 

 

Number of

 

 

Date Fair

 

For the Year Ended December 31, 2021

 

Shares

 

 

Value

 

Unvested Share-based Awards at December 31, 2020

 

 

727

 

 

$

164.58

 

Granted

 

 

293

 

 

$

268.91

 

Vested

 

 

(318

)

 

$

156.41

 

Canceled

 

 

(32

)

 

$

274.66

 

Unvested Share-based Awards at December 31, 2021

 

 

670

 

 

$

217.05

 

 

 

 

 

 

 

 

 

 

Unvested Share-based Awards expected to vest

 

 

612

 

 

$

210.15

 

 

There were no remaining stock options outstanding that could be exercised during any of the years ended December 31, 2021 and 2020. The intrinsic value of the stock options exercised by the Company’s employees during the year ended December 31, 2019 was $22.1 million.